Risk Stratification of Hepatocellular Carcinoma in Hepatitis B Virus e Antigen–Negative Carriers by Combining Viral Biomarkers | Zendy

TaiChung Tseng | Zendy; ChunJen Liu | Zendy; ChiLing Chen | Zendy; HungChih Yang | Zendy; TungHung Su | Zendy; ChiaChi Wang | Zendy; Wanting Yang | Zendy; Stephanie FangTzu Kuo | Zendy; ChenHua Liu | Zendy; PeiJer Chen | Zendy; DingShinn Chen | Zendy; JiaHorng Kao | Zendy

Open Access

Risk Stratification of Hepatocellular Carcinoma in Hepatitis B Virus e Antigen–Negative Carriers by Combining Viral Biomarkers

Author(s) -

TaiChung Tseng,

ChunJen Liu,

ChiLing Chen,

HungChih Yang,

TungHung Su,

ChiaChi Wang,

Wanting Yang,

Stephanie FangTzu Kuo,

ChenHua Liu,

PeiJer Chen,

DingShinn Chen,

JiaHorng Kao

Publication year - 2013

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1093/infdis/jit209

Subject(s) - hbsag , hepatocellular carcinoma , medicine , hbeag , hepatitis b virus , viral load , hepatitis b , virus , virology , immunology , gastroenterology

The serum hepatitis B virus (HBV) surface antigen (HBsAg) level can predict hepatocellular carcinoma (HCC) development in hepatitis B e antigen (HBeAg)-negative patients with an HBV DNA level of <2000 IU/mL. However, little is known regarding how well the combination of both viral biomarkers stratifies HCC risk.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research